Policing the promotion of prescription medicines - the new Medicines Australia Code of Conduct.
作者信息
Mintzes Barbara
出版信息
Aust Prescr. 2021 Feb;44(1):4-5. doi: 10.18773/austprescr.2020.082. Epub 2021 Feb 1.
Abstract
摘要
相似文献
1
Policing the promotion of prescription medicines - the new Medicines Australia Code of Conduct.规范处方药促销行为——澳大利亚药品行业新行为准则
Aust Prescr. 2021 Feb;44(1):4-5. doi: 10.18773/austprescr.2020.082. Epub 2021 Feb 1.
2
Advertising of antihypertensive medicines and prescription sales in Australia.澳大利亚的降压药广告和处方药销售。
Intern Med J. 2009 Nov;39(11):728-32. doi: 10.1111/j.1445-5994.2009.01909.x. Epub 2009 Feb 10.
3
Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand.扩大消费者获取药品的途径：澳大利亚和新西兰处方药转换为非处方药的比较。
PLoS One. 2015 Mar 18;10(3):e0119011. doi: 10.1371/journal.pone.0119011. eCollection 2015.
4
5
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.制药行业的药品未按批准说明书用药推广与自我监管：对英国药品使用规范管理局2003 - 2012年未按批准说明书用药推广裁决的文件分析
PLoS Med. 2016 Jan 26;13(1):e1001945. doi: 10.1371/journal.pmed.1001945. eCollection 2016 Jan.
6
Medicines Australia Code of Conduct: breaches 2019-20.澳大利亚药品行业行为准则：2019 - 2020年违规情况
Aust Prescr. 2020 Dec;43(6):210. doi: 10.18773/austprescr.2020.071. Epub 2020 Dec 1.
7
Pharmaceutical advertisements in prescribing software: an analysis.处方软件中的药品广告：一项分析
Med J Aust. 2005 Jul 18;183(2):75-9. doi: 10.5694/j.1326-5377.2005.tb06927.x.
8
Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study.澳大利亚制药公司披露的支出类型和金额变化：一项观察性研究。
BMJ Open. 2019 Feb 19;9(2):e024928. doi: 10.1136/bmjopen-2018-024928.
9
Medicines Australia Code of Conduct: breaches 2020-21.澳大利亚药品行业行为准则：2020 - 2021年违规情况
Aust Prescr. 2021 Dec;44(6):206. doi: 10.18773/austprescr.2021.057. Epub 2021 Dec 1.
10
DTCA of prescription medicines in the European Union: is there still a need for a ban?欧盟处方药的直接面向消费者的广告宣传：是否仍有必要予以禁止？
Eur J Health Law. 2010 Dec;17(5):471-84. doi: 10.1163/157180910x527897.
本文引用的文献
1
Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study.不同监管控制下的澳大利亚、加拿大和美国家庭医学期刊中处方药广告的质量：一项横断面研究。
BMJ Open. 2020 Jul 19;10(7):e034993. doi: 10.1136/bmjopen-2019-034993.
2
Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study.澳大利亚制药公司披露的支出类型和金额变化：一项观察性研究。
BMJ Open. 2019 Feb 19;9(2):e024928. doi: 10.1136/bmjopen-2018-024928.
3
Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.制药行业阿片类产品营销与阿片类药物相关过量死亡率的关联。
JAMA Netw Open. 2019 Jan 4;2(1):e186007. doi: 10.1001/jamanetworkopen.2018.6007.
4
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.欧洲的阳光政策与阴暗面：九个欧洲国家向卫生专业人员披露制药业付款情况。
Int J Health Policy Manag. 2018 Jun 1;7(6):504-509. doi: 10.15171/ijhpm.2018.20.
5
A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.澳大利亚制药行业资助的医疗专业人员活动的横断面分析。
BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701.
6
Quality of claims and references found in Australian pharmacy journal advertisements.澳大利亚药学杂志广告中声明及参考文献的质量
Int J Pharm Pract. 2017 Oct;25(5):365-370. doi: 10.1111/ijpp.12326. Epub 2016 Nov 29.
7
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.制药业赞助的餐饮与医疗保险受益人的医师处方模式
JAMA Intern Med. 2016 Aug 1;176(8):1114-1122. doi: 10.1001/jamainternmed.2016.2765.
8
Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints.药品标签外营销的策略和实践：告密者投诉的回顾性分析。
PLoS Med. 2011 Apr;8(4):e1000431. doi: 10.1371/journal.pmed.1000431. Epub 2011 Apr 5.
9
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.来自制药公司的信息以及医生处方的质量、数量和成本：系统评价。
PLoS Med. 2010 Oct 19;7(10):e1000352. doi: 10.1371/journal.pmed.1000352.
10
The haunting of medical journals: how ghostwriting sold "HRT".医学期刊的幽灵：代笔如何推销“HRT”。
PLoS Med. 2010 Sep 7;7(9):e1000335. doi: 10.1371/journal.pmed.1000335.
Zotero 插件